when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Pulmonology · news · pharmadog

← back to Pulmonology

News · Pulmonology

512 stories

Sep 3, 26STAT+: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and morestat

Sep 3, 26Akeso, Summit cancer drug confirms lung cancer survival benefitbiopharma dive

Sep 3, 26GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapybiospace

Sep 3, 26Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ dealfiercebiotech

Sep 3, 26Summit, Akeso say ivonescimab clears OS bar in Phase 3 lung cancer trialendpoints

Sep 3, 26GSK pens $1.3B Hutchmed deal for early-stage KRAS-EGFR cancer assetfiercebiotech

Sep 3, 26B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matterfda medwatch

Sep 2, 26Doctors groups release vaccination guidelines ahead of respiratory illness seasonstat

Sep 2, 26TScan axes 75% of workforce to make room for solid tumor programsfiercebiotech

Sep 2, 26Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN dealsbiospace

Sep 2, 26Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial failsbiospace

Sep 2, 26Catheter Recall Expansion: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound Cathetersfda medwatch

Sep 1, 26Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?fiercebiotech

Sep 1, 26Mid-cap biotechs join Trump’s latest round of drug pricing dealsbiopharma dive

Sep 1, 26GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modalitybiospace

Sep 1, 26Breathing Circuit Recall: Medline Removes Neonatal and Infant Heated Wire Breathing Circuitsfda medwatch

Aug 28, 26Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccinesbiopharma dive

Aug 28, 26This week in charts: Biotech’s rebound is undeniablebiopharma dive

Aug 28, 26Opinion: We quit the CDC last year. The problems we protested remainstat

Aug 27, 26FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adultsfda press

Aug 27, 26What’s in Merck and Moderna’s cancer vaccine algorithm?stat

Aug 27, 26Generate Bio drops as data accidentally leaked ahead of European conferencebiospace

Aug 27, 26RevMed could become ‘next oncology titan’ with Rasonque nodbiospace

Aug 27, 26AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitisbiospace

Aug 27, 26#ERS26: Generate Biomedicines discloses early respiratory drug data after poster leakendpoints

Aug 26, 26Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDAbiopharma dive

Aug 26, 26Summit, Akeso tout biliary cancer win for PD-1/VEGF in China—but details are pendingbiospace

Aug 26, 26Akeso, Summit hail ivonescimab's biliary tract cancer win in China-only Phase 3 trialendpoints

Aug 26, 26Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debatefiercebiotech

Aug 26, 26Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matterfda medwatch

← prevpage 6 of 18next →